These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 21327455)

  • 1. Multidisciplinary considerations in the implementation of the findings from the American College of Surgeons Oncology Group (ACOSOG) Z0011 study: a practice-changing trial.
    Caudle AS; Hunt KK; Kuerer HM; Meric-Bernstam F; Lucci A; Bedrosian I; Babiera GV; Hwang RF; Ross MI; Feig BW; Hoffman K; Litton JK; Sahin AA; Yang W; Hortobagyi GN; Buchholz TA; Mittendorf EA
    Ann Surg Oncol; 2011 Sep; 18(9):2407-12. PubMed ID: 21327455
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to the letter to the editor: Multidisciplinary considerations in the implementation of the findings from the American College of Surgeons Oncology Group (ACOSOG) Z0011 Study: a practice-changing trial.
    Caudle AS; Hunt KK; Mittendorf EA
    Ann Surg Oncol; 2011 Dec; 18 Suppl 3():S283. PubMed ID: 21725683
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of the American College of Surgeons Oncology Group (ACOSOG) Z0011 trial on clinical management of the axilla in older breast cancer patients: a SEER-medicare analysis.
    Caretta-Weyer H; Greenberg CG; Wilke LG; Weiss J; LoConte NK; Decker M; Steffens NM; Smith MA; Neuman HB
    Ann Surg Oncol; 2013 Dec; 20(13):4145-52. PubMed ID: 23959051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of the axilla: has Z0011 had an impact?
    Joyce DP; Lowery AJ; McGrath-Soo LB; Downey E; Kelly L; O'Donoghue GT; Barry M; Hill AD
    Ir J Med Sci; 2016 Feb; 185(1):145-9. PubMed ID: 25595827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The State of Surgical Axillary Management and Adjuvant Radiotherapy for Early-stage Invasive Breast Cancer in the Modern Era.
    Mann JM; Wu X; Christos P; Nagar H
    Clin Breast Cancer; 2018 Aug; 18(4):e477-e493. PubMed ID: 29031423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applicability of the ACOSOG Z0011 criteria in women with high-risk node-positive breast cancer undergoing breast conserving surgery.
    Chung A; Gangi A; Mirocha J; Giuliano A
    Ann Surg Oncol; 2015 Apr; 22(4):1128-32. PubMed ID: 25300606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of the American College of Surgeons Oncology Group (ACOSOG) Z0011 trial: An institutional review.
    Le VH; Brant KN; Blackhurst DW; Schammel CM; Schammel DP; Cornett WR; McKinley BP
    Breast; 2016 Oct; 29():117-9. PubMed ID: 27479042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Have the American College of Surgeons Oncology Group Z0011 trial results influenced the number of lymph nodes removed during sentinel lymph node dissection?
    Robinson KA; Pockaj BA; Wasif N; Kaufman K; Gray RJ
    Am J Surg; 2014 Dec; 208(6):1060-4; discussion 1063-4. PubMed ID: 25312842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. De-escalation of axillary surgery in patients outside Z0011 criteria.
    Giannakou A; Gooch J; Gergelis KR; Weiss A
    Surgery; 2023 Aug; 174(2):416-418. PubMed ID: 37156648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphovascular invasion and lobular histology are associated with increased incidence of isolated tumor cells in sentinel lymph nodes from early-stage breast cancer patients.
    Mittendorf EA; Sahin AA; Tucker SL; Meric-Bernstam F; Yi M; Nayeemuddin KM; Babiera GV; Ross MI; Feig BW; Kuerer HM; Hunt KK
    Ann Surg Oncol; 2008 Dec; 15(12):3369-77. PubMed ID: 18815841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential impact of application of Z0011 derived criteria to omit axillary lymph node dissection in node positive breast cancer patients.
    Verheuvel NC; Voogd AC; Tjan-Heijnen VC; Roumen RM
    Eur J Surg Oncol; 2016 Aug; 42(8):1162-8. PubMed ID: 27265036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of sentinel lymph node dissection alone vs. axillary lymph node dissection in early stage invasive lobular carcinoma: a retrospective study of the surveillance, epidemiology and end results (SEER) database.
    Wang J; Mittendorf EA; Sahin AA; Yi M; Caudle A; Hunt KK; Wu Y
    PLoS One; 2014; 9(2):e89778. PubMed ID: 24587029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative axillary ultrasound in breast cancer: safely avoiding frozen section of sentinel lymph nodes in breast-conserving surgery.
    Ibrahim-Zada I; Grant CS; Glazebrook KN; Boughey JC
    J Am Coll Surg; 2013 Jul; 217(1):7-15; discussion 15-6. PubMed ID: 23628226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Population-Based Study of the Effects of a Regional Guideline for Completion Axillary Lymph Node Dissection on Axillary Surgery in Patients with Breast Cancer.
    Tsao MW; Cornacchi SD; Hodgson N; Simunovic M; Thabane L; Cheng J; O'Brien MA; Strang B; Mukherjee SD; Lovrics PJ
    Ann Surg Oncol; 2016 Oct; 23(10):3354-64. PubMed ID: 27342830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expanding Implementation of ACOSOG Z0011 in Surgeon Practice.
    Weiss A; Mittendorf EA; DeSnyder SM; Hwang RF; Bea V; Bedrosian I; Hoffman K; Adrade B; Sahin AA; Kuerer HM; Hunt KK; Caudle AS
    Clin Breast Cancer; 2018 Aug; 18(4):276-281. PubMed ID: 29100726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of the ACOSOG Z0011 criteria to Chinese patients with breast cancer: a prospective study.
    Peng Y; Liu M; Li X; Tong F; Cao Y; Liu P; Zhou B; Liu H; Cheng L; Guo J; Xie F; Yang H; Wang S; Wang C; Chen Y; Wang S
    World J Surg Oncol; 2021 Apr; 19(1):128. PubMed ID: 33879180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in and outcomes from sentinel lymph node biopsy (SLNB) alone vs. SLNB with axillary lymph node dissection for node-positive breast cancer patients: experience from the SEER database.
    Yi M; Giordano SH; Meric-Bernstam F; Mittendorf EA; Kuerer HM; Hwang RF; Bedrosian I; Rourke L; Hunt KK
    Ann Surg Oncol; 2010 Oct; 17 Suppl 3(0 3):343-51. PubMed ID: 20853057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of Axillary Staging in the Management of Ductal Carcinoma In Situ.
    Van Zee KJ
    JAMA Oncol; 2015 Jun; 1(3):332-3. PubMed ID: 26181181
    [No Abstract]   [Full Text] [Related]  

  • 19. Patterns in the Use of Axillary Operations for Patients with Node-Positive Breast Cancer After Neoadjuvant Chemotherapy: A National Cancer Database (NCDB) Analysis.
    Srour MK; Tseng J; Luu M; Alban RF; Giuliano AE; Chung A
    Ann Surg Oncol; 2019 Oct; 26(10):3305-3311. PubMed ID: 31342364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial.
    Giuliano AE; Ballman KV; McCall L; Beitsch PD; Brennan MB; Kelemen PR; Ollila DW; Hansen NM; Whitworth PW; Blumencranz PW; Leitch AM; Saha S; Hunt KK; Morrow M
    JAMA; 2017 Sep; 318(10):918-926. PubMed ID: 28898379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.